Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

(2014) J. C. von Einem et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Liver only metastatic disease in patients with metastatic colorectal cancer: Impact of surgery and chemotherapy

(2013) Sunita Padman et al.   ACTA ONCOLOGICA

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer

(2013) M. K. Boisen et al.   ANNALS OF ONCOLOGY

Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut)

(2013) Dominik P. Modest et al.   ANTI-CANCER DRUGS

Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012

(2013)   Asia-Pacific Journal of Clinical Oncology

A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer

(2013) Per Jess et al.   BMJ Open

Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma

(2012) Frank Benedix et al.   PATHOLOGY RESEARCH AND PRACTICE

South Australian clinical registry for metastatic colorectal cancer

(2010) Eu Ling Neo et al.   ANZ JOURNAL OF SURGERY